The trajectory of companies tied to iconic drugs like Viagra presents a challenging investment landscape . While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key markets has introduced significant risk . Investors are now grappling with the impact of lower-cost alternatives, d